GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 86 filers reported holding GENERATION BIO CO in Q1 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $421,827 | -35.0% | 111,300 | -5.7% | 0.00% | -50.0% |
| Q2 2023 | $649,000 | +74.3% | 118,000 | +36.3% | 0.00% | +100.0% |
| Q1 2023 | $372,380 | -22.9% | 86,600 | -29.6% | 0.00% | -50.0% |
| Q4 2022 | $483,107 | -29.9% | 122,928 | -5.2% | 0.00% | 0.0% |
| Q3 2022 | $689,000 | -27.5% | 129,673 | -10.5% | 0.00% | 0.0% |
| Q2 2022 | $950,000 | -15.3% | 144,860 | -5.2% | 0.00% | 0.0% |
| Q1 2022 | $1,122,000 | +192.2% | 152,800 | +181.4% | 0.00% | +100.0% |
| Q4 2021 | $384,000 | -71.8% | 54,300 | 0.0% | 0.00% | -66.7% |
| Q3 2021 | $1,361,000 | -6.8% | 54,300 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,461,000 | -5.4% | 54,300 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $1,545,000 | +215.3% | 54,300 | +213.9% | 0.00% | +200.0% |
| Q4 2020 | $490,000 | – | 17,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $32,535,983 | 3.92% |
| GREAT POINT PARTNERS LLC | 1,022,537 | $4,018,570 | 0.79% |
| Artal Group S.A. | 2,814,191 | $11,060 | 0.62% |
| SVB FINANCIAL GROUP | 52,920 | $207,976 | 0.57% |
| PFM Health Sciences, LP | 2,903,192 | $11,409,545 | 0.41% |
| Cheyne Capital Management (UK) LLP | 51,126 | $200,925 | 0.35% |
| HighVista Strategies LLC | 138,880 | $545,798 | 0.32% |
| HARVARD MANAGEMENT CO INC | 510,354 | $2,005,691 | 0.25% |
| SECTORAL ASSET MANAGEMENT INC | 273,787 | $1,075,983 | 0.21% |
| Yiheng Capital Management, L.P. | 1,186,295 | $4,662,139 | 0.21% |